What's new

What's new

Targeted signal management (TSM) for Phenobarbital in cats and dogs

Targeted signal management (TSM) for Phenobarbital in cats and dogs

4 September 2026

Signal management (veterinary medicines)

Signal management (veterinary medicines)

4 September 2026

PSUSA/00010465/202512

PSUSA/00010465/202512

4 September 2026

PSUSA/00000269/202601

PSUSA/00000269/202601

4 September 2026

Visudyne

Visudyne

4 September 2026

PSUSA/00001345/202512

PSUSA/00001345/202512

4 September 2026

PSUSA/00000495/202601

PSUSA/00000495/202601

4 September 2026

PSUSA/00002695/202601

PSUSA/00002695/202601

4 September 2026

Human medicines European public assessment report (EPAR): Symtuza, darunavir,cobicistat,emtricitabine,tenofovir alafenamide, Date of authorisation: 21/09/2017, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR): Symtuza, darunavir,cobicistat,emtricitabine,tenofovir alafenamide, Date of authorisation: 21/09/2017, Revision: 19, Status: Authorised

4 September 2026

Opinion on medicine for use outside EU: Dengue Tetravalent Vaccine (Live, Attenuated) Takeda, Dengue virus, serotype 2, expressing Dengue virus, serotype 1, surface proteins, live, attenuated,Dengue virus, serotype 2, expressing Dengue virus, serotype 3, surface proteins, live, attenuated,Dengue virus, serotype 2, expressing Dengue virus, serotype 4, surface proteins, live, attenuated,Dengue virus, serotype 2, live, attenuated, Dengue, 13/10/2022 Positive opinion

Opinion on medicine for use outside EU: Dengue Tetravalent Vaccine (Live, Attenuated) Takeda, Dengue virus, serotype 2, expressing Dengue virus, serotype 1, surface proteins, live, attenuated,Dengue virus, serotype 2, expressing Dengue virus, serotype 3, surface proteins, live, attenuated,Dengue virus, serotype 2, expressing Dengue virus, serotype 4, surface proteins, live, attenuated,Dengue virus, serotype 2, live, attenuated, Dengue, 13/10/2022 Positive opinion

4 September 2026